Corifollitropin Alfa Compared to Daily Recombinant FSH in in Vitro Fertilization Programmes: A Meta-Analysis of Randomized-Controlled Trials
Background: Corifollitropin alfa (CFA) is a long-acting recombinant follicle-stimulating hormone (rFSH) used for controlled ovarian stimulation (COS). Several studies analyzing the clinical efficacy and safety of CFA compared to daily rFSH during COS have been carried out. The present study offers a...
Saved in:
Main Authors: | Maria Cristina Budani (Author), Stefania Fensore (Author), Marco Di Marzio (Author), Gian Mario Tiboni (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corifollitropin- α compared to daily r-FSH in for patients undergoing intracytoplasmic sperm injection: Clinical trial study
by: Ziba Zahiri Sorouri, et al.
Published: (2019) -
Corifollitropin alfa for poor responders patients, a prospective randomized study
by: F. M. Fusi, et al.
Published: (2020) -
Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients
by: Selman H, et al.
Published: (2016) -
Corifollitropin alfa application in art programs in women over 40 years
by: D A Kuleshova, et al.
Published: (2016) -
The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
by: Seyhan A, et al.
Published: (2011)